Quinolinic acid phosphoribosyl transferase moonlights as an apoptosis regulator to empower lung cancer progression
Kashfi, H.; Ilter, D.; Nicolaci, A.; Lockhart, J.; Drapela, S.; Lazure, F.; Raizada, D.; Sarigul, N.; Spegel, J.; Ward, N.; Dutta, T.; Gardell, S.; Binning, J.; Flores, E.; DeNicola, G. M.; Gomes, A. P.
Show abstract
Although nicotinamide adenine dinucleotide (NAD) metabolism is fundamental for cancer cell survival, the role of the de novo NAD biosynthetic pathway, particularly in non-small cell lung cancer (NSCLC), remains largely unknown. Here, we describe a non-canonical role for the rate-limiting enzyme in de novo NAD+ biosynthesis, quinolinate phosphoribosyltransferase (QPRT), in NSCLC progression. We show that QPRT is highly expressed in late-stage tumors and required for NSCLC growth; however, its suppression does not change NAD levels or elicit compensatory NAD biosynthetic activity. Instead, QPRT interacts with caspase-3 and suppresses its activation, protecting NSCLC cells from apoptosis. This reveals a moonlighting function for QPRT in apoptosis regulation independent of its enzymatic activity in tryptophan catabolism. Together, these findings, redefine QPRT as a protein with dual functionality and reveal it as a potential therapeutic target in NSCLC, highlighting the importance of non-canonical roles of metabolic enzymes in cancer biology. SignificanceThis study reveals that QPRT supports NSCLC progression by directly inhibiting caspase-3-mediated apoptosis independent of NAD biosynthesis, redefining its role and highlighting non-enzymatic functions of metabolic enzymes as therapeutic targets.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- PIM Kinases Alter Mitochondrial Dynamics and Chemosensitivity in Lung Cancer 97%
- DARPP-32 promotes ERBB3-mediated resistance to molecular targeted therapy in EGFR-mutated lung adenocarcinoma 96%
- Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment 95%
Similar papers in this journal
- Dependency of LKB1-inactivated lung cancer on aberrant CRTC-CREB activation 96%
- Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer 95%
- USP28 deletion and small molecule inhibition destabilises c-Myc and elicits regression of squamous cell lung carcinoma 94%
Similar papers in this journal
Similar papers in this journal
- NRF2 translation block by inhibition of cap-dependent initiation sensitizes lymphoma cells to ferroptosis and CAR-T immunotherapy 95%
- Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression 95%
- Targeting the dependence on PIK3C3-mTORC1 signaling in dormancy-prone breast cancer cells blunts metastasis initiation 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.